ERBB2 and breast carcinoma: When broken down into specific molecular subtypes such as Luminal A (Figure 6B), Luminal B (Figure 6C), HER2 amplified (Figure 6D), Basal breast cancers (Figure 6E), or estrogen receptor positive and negative (Suppl.